Latest Nectar Lifesciences stock price
Nectar Lifesciences P/E Ratio
NECLIFE • P/E ratio not applicable due to negative earnings
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company has reported losses in the last 3 quarters. P/E ratio is not applicable during loss periods.
Consecutive Loss Quarters: 3
Current EPS: ₹-5.07
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Sept 2025 | -7.85 | -176 | Loss |
| Mar 2025 | -5.80 | -130 | Loss |
| Jun 2025 | -2.82 | -63 | Loss |
| Dec 2025 | 0.64 | 14 | Profit |
| Sept 2024 | 0.25 | 6 | Profit |
| Mar 2024 | 0.03 | 1 | Profit |
| Jun 2024 | 0.13 | 3 | Profit |
| Dec 2024 | 0.35 | 8 | Profit |
Profitable Companies in Healthcare Sector
Other profitable companies in Healthcare sector with valid P/E ratios
Sector Average PE
47.74
Sector Median PE
26.65
Lowest PE
0.97
Profitable Companies
140
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 3.0 | ₹43 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.87 | ₹1,186 | Low |
| Amwill Health Care | AMWILL | 6.5 | ₹67 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹27 | Low |
| JFL Life Sciences | JFLLIFE | 7.53 | ₹36 | Low |
| Galaxy Medicare | GML | 7.66 | ₹26 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.74 | ₹2,188 | Low |
| Brooks Laboratories | BROOKS | 8.01 | ₹184 | Low |
| Zenith Drugs | ZENITHDRUG | 9.03 | ₹85 | Low |